The Long-term Safety and Efficacy of CDP6038 (Olokizumab) With Active Rheumatoid Arthritis
Clinical trial NCT01533714 · TERMINATED
Trial details
- NCT number
- NCT01533714
- Sponsor
- UCB BIOSCIENCES, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-01-26
- Primary completion
- 2013-11-27
- Enrollment
- 103
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.